Philadelphia Department of Public Health HIV Prevention ActivitiesOffice of HIV Planning
Coleman Terrell of the Philadelphia Department of Public Health presented on the PDPH's HIV Prevention Activities at the Philadelphia HIV Prevention Planning Group's December 2014 meeting.
This presentation on research about HIV self-testing in Australia was given by A/Prof Rebecca Guy, The Kirby Institute, at the AFAO Members Forum - May 2015.
These slides were presented by Dr. Henry Nagai during JSI’s Index Testing & Partner Notification for HIV Epidemic Control webinar on April 11th, 2019. Dr. Nagai is currently the Project Director/Chief of Party for the JSI-implemented USAID Strengthening the Care Continuum project in Ghana with a focus on HIV and key populations. Using funding from USAID and PEPFAR, the Project is improving the capacity of the Government of Ghana and civil society partners to provide quality and comprehensive HIV services for key populations and people living with HIV.
Expert panelists:
Dr. Tafadzwa Chakare, Technical Director, Jhpiego, Lesotho
Dr. More Mungati, STAR-L Director, EGPAF Lesotho
Facilitator:
Dr. Seema Ntjabane, Care & Treatment Specialist, USAID-Lesotho
Expert Panelists: Dr. Jason Reed, Biomedical HIV Prevention
Technical Advisor, Jhpiego & Dr. More Mungati, STAR-L Director, EGPAF, Lesotho
Moderator: Dr. Seema Ntjabane, Care & Treament Specialist, USAID-Lesotho
Philadelphia Department of Public Health HIV Prevention ActivitiesOffice of HIV Planning
Coleman Terrell of the Philadelphia Department of Public Health presented on the PDPH's HIV Prevention Activities at the Philadelphia HIV Prevention Planning Group's December 2014 meeting.
This presentation on research about HIV self-testing in Australia was given by A/Prof Rebecca Guy, The Kirby Institute, at the AFAO Members Forum - May 2015.
These slides were presented by Dr. Henry Nagai during JSI’s Index Testing & Partner Notification for HIV Epidemic Control webinar on April 11th, 2019. Dr. Nagai is currently the Project Director/Chief of Party for the JSI-implemented USAID Strengthening the Care Continuum project in Ghana with a focus on HIV and key populations. Using funding from USAID and PEPFAR, the Project is improving the capacity of the Government of Ghana and civil society partners to provide quality and comprehensive HIV services for key populations and people living with HIV.
Expert panelists:
Dr. Tafadzwa Chakare, Technical Director, Jhpiego, Lesotho
Dr. More Mungati, STAR-L Director, EGPAF Lesotho
Facilitator:
Dr. Seema Ntjabane, Care & Treatment Specialist, USAID-Lesotho
Expert Panelists: Dr. Jason Reed, Biomedical HIV Prevention
Technical Advisor, Jhpiego & Dr. More Mungati, STAR-L Director, EGPAF, Lesotho
Moderator: Dr. Seema Ntjabane, Care & Treament Specialist, USAID-Lesotho
Dr Paba Palihawadana, Chief Epidemiologist, World Hepatitis Day symposium was organized by the Sri Lanka College of Venereologists on world hepatitis day on 28. July 2015 at BMICH
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptxKritikaDhawan9
Acquired immunodeficiency syndrome (AIDS) is a chronic , potentially life, threating condition caused by the human immunodeficiency virus(HIV), a human retrovirus . By, damaging your immune system , HIV interferes with your body's ability to fight infection and disease.
HIV uses the machinery of the CD4 cells to multiply and spread throughout the body .
This lecture describes the approach to screening, diagnosis and management of HIV and TB infection among pregnant patients. Prevention of Mother to Child Transmission of HIV infection mainly based on the Philippine Obstetrical and Gynecological Society Clinical Practice Recommendations.
Ghia Fdn overview-strategy update january 2017 (presentation resaved sept 14_...Ghia Foundation
GHIA FOUNDATION WAS FOUNDED IN 2013 by a team of kind-heated Professionals.
VISION: A World where women in developing Countries live healthier , longer lives
MISSION – To reduce morbidity and mortality among women in developing Countries by strengthening Health Systems to deliver high quality, comprehensive health services.
Prevention of Mother to Child Transmission of HIV 2018Helen Madamba
Babies of pregnant women living with HIV can be born free of HIV infection. HIV counselling and testing is the gateway to diagnosis, treatment, care and support. Healthcare services need to provide enabling environments to support and empower women living with HIV and their children, to increase HIV knowledge and reduce stigma and discrimination.
The mission of the Sexually Transmitted Diseases (STD) Control Program is to reduce the occurrence of STDs through disease surveillance, case and outbreak investigation, screening, preventive therapy, outreach, diagnosis, case management, and education.
Outline:
Introduction
Epidemiologic Determinants
Mode of transmission
Burden of Hepatitis-B
Prevention and treatment
Challenges
Recent Advances in Hepatitis B research
Strategies
References
Digital screening information event 2 October 2019PHEScreening
Slides from the event for antenatal screening co-ordinators in Birmingham on 2 October 2019 to discuss the plans for moving to digital screening information.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
1. Infectious Diseases in Pregnancy
Screening Programme Update
National Laboratory Workshop 13 March 2019
Sharon Webb – National Programme Manager IDPS, PHE
2. The IDPS programme
The UK NSC assesses evidence and makes recommendations to the 4
UK governments about population screening programmes
2 IDPS Programme Update
Currently recommends systematic, population screening in
pregnancy is offered and recommended to all eligible women
HIV Hepatitis
B
Syphilis
• HSC 1999/183
• By 2000-2002
• HSC 1998/127
• By April 2000
• 1998 PHLS
systematic review
3. Aims & objectives
To:
• enable early detection and treatment for infections in
pregnancy in order to significantly reduce the risk of vertical
(mother-to-child) transmission of infection and protect the
health of the woman and her family
• ensure equal access to uniform and quality assured screening
across England
• provide women with high quality information so they can make
an informed choice about their screening options and
pregnancy choices
• provide assurance that all women who screen positive for HIV,
hepatitis B or syphilis, or are already known to be positive for
HIV and hepatitis B, are seen by the IDPS MDT within
specified timescales
3 IDPS Programme Update
4. Laboratory review
Laboratory Quality Improvements:
• clinical task group
• incidents and data reviews
o contamination management
o false positives
• laboratory handbook update
o analyses algorithms
o reporting guidance
• annual stakeholder workshop
4 IDPS Programme Update
5. Standards data
• metrics to drive continual service
improvements
• new reporting process, central
analyses and report production
• published data tables on gov.uk
• established data sharing processes
with National Infection Service (NIS)
and Field Epidemiology Services
(FES)
• trend analyses- 2-3 years of data to
inform major standards review in
2021-2023
5 IDPS Programme Update
6. Screening activity
> 850,000 conceptions to women of all ages in England and Wales
(ONS conception data 2016)
2016-17 PHE screening standards data* :
• uptake of antenatal screening for HIV, hepatitis B and syphilis in England >99%
for all three infections
• between 1,100 to 1,628 decline screening (approx. 2.5 per 1000 women)
• 0.14% (788 / 544,219) of pregnant women screened positive for HIV (new and
known diagnoses), majority are known positive
• 0.47% (2,067 / 441,696) of pregnant women screened positive for hepatitis B
infection (new and known diagnoses) ), majority are known positive
• 0.19% (837 / 446,252) of woman were reported screen positive for syphilis, 252
requiring treatment
*Exclusions are applied for missing or incomplete data submissions
6 IDPS Programme Update
7. Screening outcomes
The Screening Surveillance team at Great Ormond Street
Institute of Child Health was awarded the PHE IDPS tender
to establish the Integrated Screening Outcomes
Surveillance Service (ISOSS) in September 2018.
The goal of the ISOSS is to collect, analyse and report
obstetric and paediatric data on HIV, syphilis and
hepatitis B in pregnant women and children in order to:
• assess key outcomes of the IDPS Programme
• assess the IDPS Programme’s impact on prevention of
vertically-acquired HIV, hepatitis B and syphilis
• protect the health of women with and infants exposed
to these infections
7 IDPS Programme Update
8. IDPS ISOSS
• new governance arrangements- part of
IDPS team
• Yr 1- HIV review; plan maternal and
neonatal syphilis / maintain congenital
rubella nd syphilis
• Yr 2- roll-out maternal and neonatal
syphilis service, plan hep B service /
maintain congenital rubella nd syphilis
• Yr 3- roll-out hep B and linkage with
Imms/BBV team on newborn outcomes
8 IDPS Programme Update
9. Education
9 IDPS Programme Update
• revised generic ANNB
resource
• new IDPS eLearning package
o developed by clinicians
o interactive- 3 and 4D
media / videos and
quizzes
o recommended completion
every 2 years
o launched summer 2019
10. Information resources
Reviewed information resources for
professionals and public:
• revised handbooks into HTML
• review and update of IDPS
website and resources
• review and update screen
positive leaflets for hepatitis B,
syphilis and HIV
• information leaflet/factsheet for
women that decline screening
10 IDPS Programme Update
11. HIV
• established multidisciplinary approach
• multiple agencies involved across primary and secondary care settings
• National Surveillance of HIV in Pregnancy and Childhood (NSHPC)
collects data on all pregnant women with HIV and their babies in the
UK
• Perinatal HIV audit on 108 vertically infected children born in UK
2006-2013 for IDPS programme
• Expert Review Panel of cases to inform programme
• enhanced data collection ongoing as part of NSHPC
• NSHPC now part of IDPS Integrated Screening Outcomes Surveillance
Service (IDPS ISOSS)
12. Syphilis
• not a ‘medieval’ occurrence
• noted rise in infectious syphilis across all parts of England
• no significant increase in numbers of positive pregnant
women (approx. 800 per annum)
• approx. 43% required treatment in pregnancy
• noted ‘rise’ in cases of congenital syphilis
• acquired infection later in pregnancy
• presented late in pregnancy
• missed diagnoses
• UK NSC evidence review on retesting in later pregnancy
• BASHH guidelines and birth plan
13. PHE syphilis action plan
• collaboration with the National Infection Service STI team on
congenital syphilis review, action plan and sexual health
issues
• PHE syphilis action plan- maternity strand
• ISOSS- will collate maternal and paediatric outcomes data
• linkage to BPSU congenital syphilis case notifications
• awareness raising of sexual health in pregnancy through
stakeholder engagement, communications and regional
workshops
13 IDPS Programme Update
14. Hepatitis B
• transmission is through contact with blood and body fluids
e.g. sexual contact, sharing contaminated needles, infected
blood and blood products and transmission from mother to
baby around the time of birth
• in areas of high HBV prevalence (>8% infected) e.g. sub-
Saharan Africa, most of Asia and the Pacific islands, vertical
(mother to baby) is the most common route transmission
• the risk of developing chronic hepatitis B infection depends on
the age at which infection is acquired
• chronic infection occurs in 90% of those infected perinatally
• around 20% to 25% of individuals with chronic HBV infection
worldwide have progressive liver disease, leading to cirrhosis
in some patients and increased risk of liver cancer
IDPS Programme Update
15. WHO global health strategy on viral
hepatitis 2016 - 2021
• an estimated 250 million people worldwide are
chronically infected with HBV WHO Global
Hepatitis Report 2017
https://www.who.int/hepatitis/publications/global-
hepatitis-report2017/en/
• international public health challenge comparable to
HIV, TB and malaria
• acknowledged largely ignored issue
• the first global health sector strategy on viral
hepatitis, 2030 Agenda for Sustainable
Development: Target 3
• specific action to combat viral hepatitis and aim to
eliminate it as a public health threat
15 IDPS Programme Update
16. Main points
• strategy addresses all five hepatitis viruses (hepatitis A,
B, C, D and E)
• a particular focus on hepatitis B and C, owing to the
relative public health burden they represent
• provides a vision of a world where:
• viral hepatitis transmission is halted
• everyone living with viral hepatitis has access to safe,
affordable and effective care and treatment;
• a goal of eliminating viral hepatitis as a major public
health threat by 2030
16 IDPS Programme Update
17. 5 core intervention areas
1. Vaccines-
• A,B,E available
• Large scale hep B childhood programmes
2. Prevention of mother-to-child transmission of hepatitis B
• Antenatal testing
• Antivirals in pregnancy
• Timely birth dose
3. Injection, blood and surgical safety
• Universal precautions and safety measures
• Safe blood products
4. Harm reduction for people who inject drugs
• Access to sterile equipment and drug dependence treatments
5. Treatment
• Effective treatment and monitoring regimensIDPS Programme Update17 An update on the IDPS Programme and the targeted neonatal hep B imms programme
18. Why should we bother?
A vaccine against hepatitis B
has been available since
1982. The vaccine is 95%
effective in preventing
infection and the development
of chronic disease and liver
cancer due to hepatitis B.
18 IDPS Programme Update
19. Why should we bother?
We have overwhelming evidence mainly from screening
safety incidents and serious incidents that there are
weaknesses in the current pathway- we can
always improve!
19 IDPS Programme Update
20. What can we do?
• PHE liver strategy
• PHE screening and immunisation quality improvement
initiative 2017-2020
• improved surveillance systems
• gold standard care in line with HIV
• increase public awareness and knowledge
• improve professional knowledge
• increase multidisciplinary working
20 IDPS Programme Update
22. What do the pathways tell us?
• WHO- define roles and
responsibilities to ensure
seamless handover of care
• WHEN- establish key
timescales for effective care
provision
• WHAT- the care you need to
provide at each stage
• WHY- evidence, safety,
standards, guidelines, equality
and access
22 IDPS Programme Update
Improve outcomes
for women, their
babies and their
extended family
23. The HIV model
• long standing multidisciplinary approach
• resource rich area of health care
• multiple agencies involved across primary and
secondary care settings
• addresses complex physical, social and emotional needs
• collaborative working and care planning
23 IDPS Programme Update
24. Key messages- generic
Updated pathways referenced in the service specifications
2019/2020
updated version of screening and laboratory handbooks in
2019
➢ check all results at every contact
➢ management of women who decline in a timely manner
➢ care of women who miscarry after screening
- trust process in place
➢ triage into clinical care and multidisciplinary working
➢ work as a team- involve members of MDT
➢ support improvement of screening on delivery suites
24 IDPS Programme Update
25. Key messages- women with hepatitis B
Screening team co-ordinate care package from start to finish
➢ never presume known positive women understand their condition
and the care they will need to protect their babies
➢ information giving on data collection, disease notification and
national surveillance processes important
➢ all newly diagnosed women need clinical assessment for their new
diagnoses
➢ establish who orders the HBIG - work together
➢ third trimester review-
➢important to individualise care for each woman
➢check understanding of care at delivery and beyond
➢repeat info about schedule, registration of birth and with GP
25 IDPS Programme Update
26. Key messages- delivery and postnatal
26 IDPS Programme Update
• check every woman’s results on
admission
• offer and recommend screening if no
reliable results in labour
• expedite lab testing
• notify screening team to follow up
• PHE HBIG box
• maternal serology sample
• neonatal dried bloodspot
• HBIG box and paperwork back to
screening team complete the
notifications to primary care and CHIS
and ISOSS
27. Investigating hepatitis B vaccine failures
In spite of vaccine/HBIG intervention, hepatitis B infected babies are still
seen, possibly due to:
• inter-uterine transfer of infection, or perinatal transmission
• important factors in vaccine/HBIG failure include maternal viral load and
mutant hepatitis B viruses that “escape” the vaccine
PHE surveillance process to collate data needed to inform interventions to
prevent transmission by:
• assessing maternal HBV DNA levels at 2 time points
1. Screening – HBV DNA levels at the early phase of pregnancy
2. Delivery - HBV DNA levels at time of birth
• assessing markers of HBV infection in baby at 2 time points
1. At birth – HBV DNA
2. 12 month – HBsAg, anti-HBc
27 IDPS Programme Update
28. Professional Guidance
28 IDPS Programme Update
• Previous “best practice”
published in 2011 is now
out of date
• New supporting
guidance is being
developed to support the
quality improvement
initiative
29. Supporting resources
• IDPS screen positive leaflet
• PHE vaccination leaflet
• prepaid serology packages
• PHE hepatitis B safety checklist
• notification letter templates
• delivery suite ‘HBIG box’
• red book inserts
• primary care aide memoire
• eLearning modules
29 IDPS Programme Update